Search

Your search keyword '"Geary, Peter"' showing total 11 results
Start Over Author "Geary, Peter"
11 results on '"Geary, Peter"'

2. The co-crystallisation of sugars by the supersaturation process

Author

Geary, Peter Michael, Mackenzie, Grahame, and Francesconi, Grazia

Subjects
547.78, Physical science
Abstract

Co-crystallising sugars by the supersaturation process was investigated using sucrose and lactose as the matrix sugars. The components to be cocrystallised with either sucrose or lactose were a variety of mono- and disaccharides along with sweeteners such as saccharin. Analysis of the materials yielded from the supersaturation process was done primarily by differential scanning Calorimetry (DSC) and powder x-ray diffraction (PXRD). DSC analysis allowed information to be obtained on the thermal behaviour of the various co-crystalline materials, whilst PXRD permitted information on the structural aspects of the materials to be gained. These two forms of analysis were complimentary to each other, each revealed unique characteristics of the co-crystalline materials. To unambiguously differentiate the difference between a material that is co-crystalline and one that is not, physical blends of the sugars to be cocrystallised were analysed by DSC and PXRD. This approach allowed for identification of all the components in the mixture, more importantly, this identification was achievable at all levels of the second component in the mixture. Co-crystallising either sucrose or lactose, with various sugars, yielded solely co-crystalline material up to a certain level of the added sugar. Once this level has been reached, two distinct phases appear in both DSC and PXRD analysis. A co-crystallised and a phase relating to the added sugar can be observed. The formation of a potentially co-crystalline material appears to result from a direct inclusion of the added sugar into the matrix sugar. DSC analysis of the co-crystallised material revealed thermal behaviour that is suggestive of a doping of the matrix sugar by the added component. PXRD analysis did provide some data to further this argument, axis elongation for co-crystallised material is suggestive of a sopping of the main phase. However, determination of the unit cell volumes did not yield conclusive evidence to help prove this hypothesis though. This behaviour in both forms of analysis was generally proportional to the quantity of the second component that has become included into the matrix sugar. The formation of solely co-crystalline materials appears to rely on the structural similarity between the matrix sugar and the component to be included. A higher degree of similarity is reflected by a high level of inclusion of the added component. Co-crystallisation appears to rely on a degree of intermolecular sugar-sugar recognition. The inclusion of a second component is not solely down to structural similarities between materials however. It appears that there are kinetic factors potentially involved to. Varying the method of co-crystallisation allowed for higher, or lower, amounts of various second components to be included within a matrix sugar. The appearance of co-crystalline materials may be due to the inclusion of the second component in an amorphous state. Analysis by Autosorb of various co-crystalline materials has dispelled this idea. All co-crystalline materials behaved in a manner that was indicative of a crystalline material. During the course of the work with sucrose, it was noted that a unique melting point was observed. From previous work, this unique phase was thought to be a hydrated form of sucrose. Further analysis on this material has allowed for further postulation on its formation and on new methods of its synthesis.

Published
2008

3. International network of cancer genome projects

Author

Hudson (Chairperson), Thomas J, Anderson, Warwick, Aretz, Axel, Barker, Anna D, Bell, Cindy, Bernabé, Rosa R, Bhan, MK, Calvo, Fabien, Eerola, Iiro, Gerhard, Daniela S, Guttmacher, Alan, Guyer, Mark, Hemsley, Fiona M, Jennings, Jennifer L, Kerr, David, Klatt, Peter, Kolar, Patrik, Kusuda, Jun, Lane, David P, Laplace, Frank, Lu, Youyong, Nettekoven, Gerd, Ozenberger, Brad, Peterson, Jane, Rao, TS, Remacle, Jacques, Schafer, Alan J, Shibata, Tatsuhiro, Stratton, Michael R, Vockley, Joseph G, Watanabe, Koichi, Yang, Huanming, Yuen, Matthew MF, Knoppers (Leader), Bartha M, Bobrow, Martin, Cambon-Thomsen, Anne, Dressler, Lynn G, Dyke, Stephanie OM, Joly, Yann, Kato, Kazuto, Kennedy, Karen L, Nicolás, Pilar, Parker, Michael J, Rial-Sebbag, Emmanuelle, Romeo-Casabona, Carlos M, Shaw, Kenna M, Wallace, Susan, Wiesner, Georgia L, Zeps, Nikolajs, Lichter (Leader), Peter, Biankin, Andrew V, Chabannon, Christian, Chin, Lynda, Clément, Bruno, de Alava, Enrique, Degos, Françoise, Ferguson, Martin L, Geary, Peter, Hayes, D Neil, Hudson, Thomas J, Johns, Amber L, Kasprzyk, Arek, Nakagawa, Hidewaki, Penny, Robert, Piris, Miguel A, Sarin, Rajiv, Scarpa, Aldo, van de Vijver, Marc, Futreal (Leader), P Andrew, Aburatani, Hiroyuki, Bayés, Mónica, Bowtell, David DL, Campbell, Peter J, Estivill, Xavier, Grimmond, Sean M, Gut, Ivo, Hirst, Martin, López-Otín, Carlos, Majumder, Partha, Marra, Marco, McPherson, John D, Ning, Zemin, Puente, Xose S, Ruan, Yijun, Stunnenberg, Hendrik G, Swerdlow, Harold, Velculescu, Victor E, Wilson, Richard K, Xue, Hong H, Yang, Liu, Spellman (Leader), Paul T, Bader, Gary D, Boutros, Paul C, and Flicek, Paul

Subjects
Cancer, Genetics, Human Genome, DNA Methylation, DNA Mutational Analysis, Databases, Genetic, Genes, Neoplasm, Genetics, Medical, Genome, Human, Genomics, Humans, Intellectual Property, International Cooperation, Mutation, Neoplasms, International Cancer Genome Consortium, General Science & Technology
Abstract

The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.

Published
2010

4. International network of cancer genome projects.

Author

International Cancer Genome Consortium, Hudson, Thomas J, Anderson, Warwick, Artez, Axel, Barker, Anna D, Bell, Cindy, Bernabé, Rosa R, Bhan, MK, Calvo, Fabien, Eerola, Iiro, Gerhard, Daniela S, Guttmacher, Alan, Guyer, Mark, Hemsley, Fiona M, Jennings, Jennifer L, Kerr, David, Klatt, Peter, Kolar, Patrik, Kusada, Jun, Lane, David P, Laplace, Frank, Youyong, Lu, Nettekoven, Gerd, Ozenberger, Brad, Peterson, Jane, Rao, TS, Remacle, Jacques, Schafer, Alan J, Shibata, Tatsuhiro, Stratton, Michael R, Vockley, Joseph G, Watanabe, Koichi, Yang, Huanming, Yuen, Matthew MF, Knoppers, Bartha M, Bobrow, Martin, Cambon-Thomsen, Anne, Dressler, Lynn G, Dyke, Stephanie OM, Joly, Yann, Kato, Kazuto, Kennedy, Karen L, Nicolás, Pilar, Parker, Michael J, Rial-Sebbag, Emmanuelle, Romeo-Casabona, Carlos M, Shaw, Kenna M, Wallace, Susan, Wiesner, Georgia L, Zeps, Nikolajs, Lichter, Peter, Biankin, Andrew V, Chabannon, Christian, Chin, Lynda, Clément, Bruno, de Alava, Enrique, Degos, Françoise, Ferguson, Martin L, Geary, Peter, Hayes, D Neil, Johns, Amber L, Kasprzyk, Arek, Nakagawa, Hidewaki, Penny, Robert, Piris, Miguel A, Sarin, Rajiv, Scarpa, Aldo, van de Vijver, Marc, Futreal, P Andrew, Aburatani, Hiroyuki, Bayés, Mónica, Botwell, David DL, Campbell, Peter J, Estivill, Xavier, Grimmond, Sean M, Gut, Ivo, Hirst, Martin, López-Otín, Carlos, Majumder, Partha, Marra, Marco, McPherson, John D, Ning, Zemin, Puente, Xose S, Ruan, Yijun, Stunnenberg, Hendrik G, Swerdlow, Harold, Velculescu, Victor E, Wilson, Richard K, Xue, Hong H, Yang, Liu, Spellman, Paul T, Bader, Gary D, and Boutros, Paul C

Subjects
International Cancer Genome Consortium, Humans, Neoplasms, DNA Mutational Analysis, Genetics, Medical, Genomics, DNA Methylation, Mutation, Genome, Human, International Cooperation, Intellectual Property, Databases, Genetic, Genes, Neoplasm, Genetics, Medical, Genome, Human, Databases, Genetic, Genes, Neoplasm, General Science & Technology
Abstract

The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies.

Published
2010

7. International network of cancer genome projects

Author

Hudson, Thomas J., Anderson, Warwick, Aretz, Axel, Barker, Anna D., Bell, Cindy, Bernabe, Rosa R., Bhan, M. K., Calvo, Fabien, Eerola, Iiro, Gerhard, Daniela S., Guttmacher, Alan, Guyer, Mark, Hemsley, Fiona M., Jennings, Jennifer L., Kerr, David, Klatt, Peter, Kolar, Patrik, Kusuda, Jun, Lane, David P., Laplace, Frank, Lu, Youyong, Nettekoven, Gerd, Ozenberger, Brad, Peterson, Jane, Rao, T. S., Remacle, Jacques, Schafer, Alan J., Shibata, Tatsuhiro, Stratton, Michael R., Vockley, Joseph G., Watanabe, Koichi, Yang, Huanming, Yuen, Matthew M. F., Knoppers, M., Bobrow, Martin, Cambon-Thomsen, Anne, Dressler, Lynn G., Dyke, Stephanie O. M., Joly, Yann, Kato, Kazuto, Kennedy, Karen L., Nicolas, Pilar, Parker, Michael J., Rial-Sebbag, Emmanuelle, Romeo-Casabona, Carlos M., Shaw, Kenna M., Wallace, Susan, Wiesner, Georgia L., Zeps, Nikolajs, Lichter, Peter, Biankin, Andrew V., Chabannon, Christian, Chin, Lynda, Clement, Bruno, de Alava, Enrique, Degos, Francoise, Ferguson, Martin L., Geary, Peter, Hayes, D. Neil, Johns, Amber L., Nakagawa, Hidewaki, Penny, Robert, Piris, Miguel A., Sarin, Rajiv, Scarpa, Aldo, van de Vijver, Marc, Futreal, P. Andrew, Aburatani, Hiroyuki, Bayes, Monica, Bowtell, David D. L., Campbell, Peter J., Estivill, Xavier, Grimmond, Sean M., Gut, Ivo, Hirst, Martin, Lopez-Otin, Carlos, Majumder, Partha, Marra, Marco, Ning, Zemin, Puente, Xose S., Ruan, Yijun, Stunnenberg, Hendrik G., Swerdlow, Harold, Velculescu, Victor E., Wilson, Richard K., Xue, Hong H., Yang, Liu, Spellman, Paul T., Bader, Gary D., Boutros, Paul C., Flicek, Paul, Getz, Gad, Guigo, Roderic, Guo, Guangwu, Haussler, David, Heath, Simon, Hubbard, Tim J., Jiang, Tao, Jones, Steven M., Li, Qibin, Lopez-Bigas, Nuria, Luo, Ruibang, Pearson, John V., Quesada, Victor, Raphael, Benjamin J., Sander, Chris, Speed, Terence P., Stuart, Joshua M., Teague, Jon W., Totoki, Yasushi, Tsunoda, Tatsuhiko, Valencia, Alfonso, Wheeler, David A., Wu, Honglong, Zhao, Shancen, Zhou, Guangyu, Stein, Lincoln D., Lathrop, Mark, Ouellette, B. F. Francis, Thomas, Gilles, Yoshida, Teruhiko, Axton, Myles, Gunter, Chris, McPherson, John D., Miller, Linda J., Kasprzyk, Arek, Zhang, Junjun, Haider, Syed A., Wang, Jianxin, Yung, Christina K., Cros, Anthony, Liang, Yong, Gnaneshan, Saravanamuttu, Guberman, Jonathan, Hsu, Jack, Chalmers, Don R. C., Hasel, Karl W., Kaan, Terry S. H., Knoppers, Bartha M., Lowrance, William W., Masui, Tohru, Rodriguez, Laura Lyman, Vergely, Catherine, Cloonan, Nicole, Defazio, Anna, Eshleman, James R., Etemadmoghadam, Dariush, Gardiner, Brooke B., Kench, James G., Sutherland, Robert L., Tempero, Margaret A., Waddell, Nicola J., Wilson, Peter J., Gallinger, Steve, Tsao, Ming-Sound, Shaw, Patricia A., Petersen, Gloria M., Mukhopadhyay, Debabrata, DePinho, Ronald A., Thayer, Sarah, Muthuswamy, Lakshmi, Shazand, Kamran, Beck, Timothy, Sam, Michelle, Timms, Lee, Ballin, Vanessa, Ji, Jiafu, Zhang, Xiuqing, Chen, Feng, Hu, Xueda, Yang, Qi, Tian, Geng, Zhang, Lianhai, Xing, Xiaofang, Li, Xianghong, Zhu, Zhenggang, Yu, Yingyan, Yu, Jun, Tost, Joerg, Brennan, Paul, Holcatova, Ivana, Zaridze, David, Brazma, Alvis, Egevad, Lars, Prokhortchouk, Egor, Banks, Rosamonde Elizabeth, Uhlén, Mathias, Viksna, Juris, Pontén, Fredrik, Skryabin, Konstantin, Birney, Ewan, Borg, Ake, Borresen-Dale, Anne-Lise, Caldas, Carlos, Foekens, John A., Martin, Sancha, Reis-Filho, Jorge S., Richardson, Andrea L., Sotiriou, Christos, van't Veer, Laura, Birnbaum, Daniel, Blanche, Helene, Boucher, Pascal, Boyault, Sandrine, Masson-Jacquemier, Jocelyne D., Pauporte, Iris, Pivot, Xavier, Vincent-Salomon, Anne, Tabone, Eric, Theillet, Charles, Treilleux, Isabelle, Bioulac-Sage, Paulette, Decaens, Thomas, Franco, Dominique, Gut, Marta, Samuel, Didier, Zucman-Rossi, Jessica, Eils, Roland, Brors, Benedikt, Korbel, Jan O., Korshunov, Andrey, Landgraf, Pablo, Lehrach, Hans, Pfister, Stefan, Radlwimmer, Bernhard, Reifenberger, Guido, Taylor, Michael D., von Kalle, Christof, Majumder, Partha P., Pederzoli, Paolo, Lawlor, Rita T., Delledonne, Massimo, Bardelli, Alberto, Gress, Thomas, Klimstra, David, Zamboni, Giuseppe, Nakamura, Yusuke, Miyano, Satoru, Fujimoto, Akihiro, Campo, Elias, de Sanjose, Silvia, Montserrat, Emili, Gonzalez-Diaz, Marcos, Jares, Pedro, Himmelbauer, Heinz, Bea, Silvia, Aparicio, Samuel, Easton, Douglas F., Collins, Francis S., Compton, Carolyn C., Lander, Eric S., Burke, Wylie, Green, Anthony R., Hamilton, Stanley R., Kallioniemi, Olli P., Ley, Timothy J., Liu, Edison T., Wainwright, Brandon J., Hudson, Thomas J., Anderson, Warwick, Aretz, Axel, Barker, Anna D., Bell, Cindy, Bernabe, Rosa R., Bhan, M. K., Calvo, Fabien, Eerola, Iiro, Gerhard, Daniela S., Guttmacher, Alan, Guyer, Mark, Hemsley, Fiona M., Jennings, Jennifer L., Kerr, David, Klatt, Peter, Kolar, Patrik, Kusuda, Jun, Lane, David P., Laplace, Frank, Lu, Youyong, Nettekoven, Gerd, Ozenberger, Brad, Peterson, Jane, Rao, T. S., Remacle, Jacques, Schafer, Alan J., Shibata, Tatsuhiro, Stratton, Michael R., Vockley, Joseph G., Watanabe, Koichi, Yang, Huanming, Yuen, Matthew M. F., Knoppers, M., Bobrow, Martin, Cambon-Thomsen, Anne, Dressler, Lynn G., Dyke, Stephanie O. M., Joly, Yann, Kato, Kazuto, Kennedy, Karen L., Nicolas, Pilar, Parker, Michael J., Rial-Sebbag, Emmanuelle, Romeo-Casabona, Carlos M., Shaw, Kenna M., Wallace, Susan, Wiesner, Georgia L., Zeps, Nikolajs, Lichter, Peter, Biankin, Andrew V., Chabannon, Christian, Chin, Lynda, Clement, Bruno, de Alava, Enrique, Degos, Francoise, Ferguson, Martin L., Geary, Peter, Hayes, D. Neil, Johns, Amber L., Nakagawa, Hidewaki, Penny, Robert, Piris, Miguel A., Sarin, Rajiv, Scarpa, Aldo, van de Vijver, Marc, Futreal, P. Andrew, Aburatani, Hiroyuki, Bayes, Monica, Bowtell, David D. L., Campbell, Peter J., Estivill, Xavier, Grimmond, Sean M., Gut, Ivo, Hirst, Martin, Lopez-Otin, Carlos, Majumder, Partha, Marra, Marco, Ning, Zemin, Puente, Xose S., Ruan, Yijun, Stunnenberg, Hendrik G., Swerdlow, Harold, Velculescu, Victor E., Wilson, Richard K., Xue, Hong H., Yang, Liu, Spellman, Paul T., Bader, Gary D., Boutros, Paul C., Flicek, Paul, Getz, Gad, Guigo, Roderic, Guo, Guangwu, Haussler, David, Heath, Simon, Hubbard, Tim J., Jiang, Tao, Jones, Steven M., Li, Qibin, Lopez-Bigas, Nuria, Luo, Ruibang, Pearson, John V., Quesada, Victor, Raphael, Benjamin J., Sander, Chris, Speed, Terence P., Stuart, Joshua M., Teague, Jon W., Totoki, Yasushi, Tsunoda, Tatsuhiko, Valencia, Alfonso, Wheeler, David A., Wu, Honglong, Zhao, Shancen, Zhou, Guangyu, Stein, Lincoln D., Lathrop, Mark, Ouellette, B. F. Francis, Thomas, Gilles, Yoshida, Teruhiko, Axton, Myles, Gunter, Chris, McPherson, John D., Miller, Linda J., Kasprzyk, Arek, Zhang, Junjun, Haider, Syed A., Wang, Jianxin, Yung, Christina K., Cros, Anthony, Liang, Yong, Gnaneshan, Saravanamuttu, Guberman, Jonathan, Hsu, Jack, Chalmers, Don R. C., Hasel, Karl W., Kaan, Terry S. H., Knoppers, Bartha M., Lowrance, William W., Masui, Tohru, Rodriguez, Laura Lyman, Vergely, Catherine, Cloonan, Nicole, Defazio, Anna, Eshleman, James R., Etemadmoghadam, Dariush, Gardiner, Brooke B., Kench, James G., Sutherland, Robert L., Tempero, Margaret A., Waddell, Nicola J., Wilson, Peter J., Gallinger, Steve, Tsao, Ming-Sound, Shaw, Patricia A., Petersen, Gloria M., Mukhopadhyay, Debabrata, DePinho, Ronald A., Thayer, Sarah, Muthuswamy, Lakshmi, Shazand, Kamran, Beck, Timothy, Sam, Michelle, Timms, Lee, Ballin, Vanessa, Ji, Jiafu, Zhang, Xiuqing, Chen, Feng, Hu, Xueda, Yang, Qi, Tian, Geng, Zhang, Lianhai, Xing, Xiaofang, Li, Xianghong, Zhu, Zhenggang, Yu, Yingyan, Yu, Jun, Tost, Joerg, Brennan, Paul, Holcatova, Ivana, Zaridze, David, Brazma, Alvis, Egevad, Lars, Prokhortchouk, Egor, Banks, Rosamonde Elizabeth, Uhlén, Mathias, Viksna, Juris, Pontén, Fredrik, Skryabin, Konstantin, Birney, Ewan, Borg, Ake, Borresen-Dale, Anne-Lise, Caldas, Carlos, Foekens, John A., Martin, Sancha, Reis-Filho, Jorge S., Richardson, Andrea L., Sotiriou, Christos, van't Veer, Laura, Birnbaum, Daniel, Blanche, Helene, Boucher, Pascal, Boyault, Sandrine, Masson-Jacquemier, Jocelyne D., Pauporte, Iris, Pivot, Xavier, Vincent-Salomon, Anne, Tabone, Eric, Theillet, Charles, Treilleux, Isabelle, Bioulac-Sage, Paulette, Decaens, Thomas, Franco, Dominique, Gut, Marta, Samuel, Didier, Zucman-Rossi, Jessica, Eils, Roland, Brors, Benedikt, Korbel, Jan O., Korshunov, Andrey, Landgraf, Pablo, Lehrach, Hans, Pfister, Stefan, Radlwimmer, Bernhard, Reifenberger, Guido, Taylor, Michael D., von Kalle, Christof, Majumder, Partha P., Pederzoli, Paolo, Lawlor, Rita T., Delledonne, Massimo, Bardelli, Alberto, Gress, Thomas, Klimstra, David, Zamboni, Giuseppe, Nakamura, Yusuke, Miyano, Satoru, Fujimoto, Akihiro, Campo, Elias, de Sanjose, Silvia, Montserrat, Emili, Gonzalez-Diaz, Marcos, Jares, Pedro, Himmelbauer, Heinz, Bea, Silvia, Aparicio, Samuel, Easton, Douglas F., Collins, Francis S., Compton, Carolyn C., Lander, Eric S., Burke, Wylie, Green, Anthony R., Hamilton, Stanley R., Kallioniemi, Olli P., Ley, Timothy J., Liu, Edison T., and Wainwright, Brandon J.

Abstract

The International Cancer Genome Consortium (ICGC) was launched to coordinate large-scale cancer genome studies in tumours from 50 different cancer types and/or subtypes that are of clinical and societal importance across the globe. Systematic studies of more than 25,000 cancer genomes at the genomic, epigenomic and transcriptomic levels will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define clinically relevant subtypes for prognosis and therapeutic management, and enable the development of new cancer therapies., QC 20110114

Published
2010
Full Text
View/download PDF

8. Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research

Author

Pitt, Karen, Campbell, Lori, Skubitz, Amy, Somiari, Stella, Sexton, Katherine, Pugh, Rebecca, Aamodt, Roger, Baird, Phil, Betsou, Fay, Cohen, Laurent, De Souza, Yvonne, Gaffney, Eoin, Geary, Peter, Grizzle, William E., Gunter, Elaine, Horsefall, David, Kessler, Joseph, Kaercher, Edward, Michels, Cheryl, Morales, Oscar, Morente, Manuel, Morrin, Helen, Petersen, Gitte, Riegman, Peter, Rob, James, Seberg, Ole, Thomas, Jeffrey, Thorne, Heather, Walters, Chris, Pitt, Karen, Campbell, Lori, Skubitz, Amy, Somiari, Stella, Sexton, Katherine, Pugh, Rebecca, Aamodt, Roger, Baird, Phil, Betsou, Fay, Cohen, Laurent, De Souza, Yvonne, Gaffney, Eoin, Geary, Peter, Grizzle, William E., Gunter, Elaine, Horsefall, David, Kessler, Joseph, Kaercher, Edward, Michels, Cheryl, Morales, Oscar, Morente, Manuel, Morrin, Helen, Petersen, Gitte, Riegman, Peter, Rob, James, Seberg, Ole, Thomas, Jeffrey, Thorne, Heather, and Walters, Chris

Published
2008

11. Comprehensive cancer control-research & development: knowing what we do and doing what we know

Author

Kerner, Jon F, Cazap, Eduardo, Yach, Derek, Pierotti, Marco A, Daidone, Maria Grazia, de Blasio, Pasquale, Geary, Peter, Schacter, Brent, Sant, Milena, Habbema, J Dik F, Sankaranarayanan, Rengaswamy, Sutcliffe, Catherine, and Sutcliffe, Simon

Abstract

Comprehensive cancer control is defined as an integrated and coordinated approach to reducing cancer incidence, morbidity, and mortality across the cancer control continuum from primary prevention to end-of-life care. This approach assumes that when the public sector, non-governmental organizations, academia, and the private sector share with each other their skills, knowledge, and resources, a country can take advantage of all its talents and resources to more quickly reduce the burden of cancer for all its population. One critical issue for comprehensive cancer control is the extent to which the private sector can contribute to cancer prevention and control programs and policies that have historically been lead by the public health sector, and similarly how can the public sector increase its investment and involvement in clinical research and practice issues that are largely driven by the private sector worldwide?In addition, building capacity to integrate research that is appropriate to the culture and context of the population will be important in different settings, in particular research related to cancer control interventions that have the capacity to influence outcomes. To whatever extent cancer control research is ultimately funded through the private and public sectors, if investments in research discoveries are ultimately to benefit the populations that bear the greatest burden of disease, then new approaches to integrating the lessons learned from science with the lessons learned from service (public health, clinical, and public policy) must be found to close the gap between what we know and what we do. Communities of practice for international cancer control, like the ones fostered by the first three International Cancer Control Congresses, represent an important forum for knowledge exchange opportunities to accelerate the translation of new knowledge into action to reduce the burden of cancer worldwide.

Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results